Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.90
-0.03 (-0.27%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Corvus Pharmaceuticals Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Income Operating Income Growth | -19.3 | -14.88 | -12.22 | -10.57 | -10.26 | -9.92 | -8.11 | -7.26 | -5.94 | -6.25 | -5.63 | -5.56 | -5.62 | -6.52 | -5.52 | -12.33 | -6.87 | -7.27 | -6.67 | -8.95 |
Net Income Net Income Growth | -17.96 | -13.69 | -12.32 | -10.16 | -8 | 15.19 | -12.11 | -40.22 | -4.26 | -5.7 | -6.65 | -6 | -6.5 | -7.87 | -9.82 | -14.83 | -8.36 | -8.3 | -9.24 | -10.67 |
Earnings Per Share EPS Growth | -0.19 | -0.15 | -0.15 | -0.12 | -0.10 | -0.13 | -0.18 | -0.60 | -0.07 | -0.12 | -0.14 | -0.12 | -0.14 | -0.17 | -0.21 | -0.32 | -0.18 | -0.18 | -0.20 | -0.24 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 215.23 | 236.71 | 56.75 | 65.69 | 74.41 | 44.21 | 51.96 | 41.65 | 47.25 | 22.13 | 27.15 | 32.17 | 37.02 | 34.47 | 42.3 | 49.62 | 56.72 | 62.94 | 69.45 | 76.33 |
Total Debt Total Debt Growth | 0.73 | 0.83 | 0.94 | 1.01 | 1.08 | 1.15 | 1.12 | 0.35 | 0.7 | 1.04 | 1.37 | 1.69 | 2 | 2.3 | 2.6 | 2.87 | 3.13 | 3.39 | 3.65 | 3.89 |
Net Cash (Debt) Net Cash Growth | 214.5 | 235.88 | 55.81 | 64.68 | 73.32 | 43.06 | 50.84 | 41.3 | 46.55 | 21.09 | 25.78 | 30.48 | 35.02 | 32.16 | 39.7 | 46.75 | 53.59 | 59.55 | 65.8 | 72.44 |
Net Cash Growth | 192.54% | 447.81% | 9.78% | 56.62% | 57.53% | 104.19% | 97.25% | 35.50% | 32.92% | -34.44% | -35.08% | -34.80% | -34.65% | -45.99% | -39.67% | -35.47% | -17.14% | -9.66% | 56.87% | 48.38% |
Net Cash Per Share Net Cash Per Share Growth | 2.32 | 2.62 | 0.67 | 0.78 | 0.94 | 0.57 | 0.74 | 0.62 | 0.78 | 0.43 | 0.53 | 0.62 | 0.74 | 0.69 | 0.85 | 1.00 | 1.15 | 1.28 | 1.41 | 1.65 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -15.4 | -10.37 | -9.19 | -9.57 | -5.78 | -8.26 | -8.47 | -6.32 | -5.48 | -5.16 | -5.17 | -5.43 | -5.22 | -8.11 | -7.55 | -6.93 | -6.12 | -6.42 | -6.86 | -8.43 |
Capital Expenditures CapEx Growth | -0.58 | -0.09 | -0.03 | - | -0.11 | -0.04 | - | - | - | - | - | - | - | -0.03 | - | -0.27 | -0 | - | -0.01 | - |
Free Cash Flow Free Cash Flow Growth | -15.98 | -10.47 | -9.22 | -9.57 | -5.89 | -8.3 | -8.47 | -6.32 | -5.48 | -5.16 | -5.17 | -5.43 | -5.22 | -8.15 | -7.55 | -7.19 | -6.13 | -6.42 | -6.86 | -8.43 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Selected indicators aren't available for this stock.